PMV Pharmaceuticals Inc PMVP:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:08 PM EDT
2.20quote price arrow down-0.01 (-0.45%)
Volume
125,769
Close
2.21quote price arrow up+0.11 (+5.24%)
Volume
264,257
52 week range
1.17 - 9.72
Loading...
  • Open2.09
  • Day High2.21
  • Day Low2.09
  • Prev Close2.10
  • 52 Week High9.72
  • 52 Week High Date08/10/23
  • 52 Week Low1.17
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap113.69M
  • Shares Out51.44M
  • 10 Day Average Volume0.60M
  • Dividend-
  • Dividend Yield-
  • Beta1.61
  • YTD % Change-28.71

KEY STATS

  • Open2.09
  • Day High2.21
  • Day Low2.09
  • Prev Close2.10
  • 52 Week High9.72
  • 52 Week High Date08/10/23
  • 52 Week Low1.17
  • 52 Week Low Date10/27/23
  • Market Cap113.69M
  • Shares Out51.44M
  • 10 Day Average Volume0.60M
  • Dividend-
  • Dividend Yield-
  • Beta1.61
  • YTD % Change-28.71

RATIOS/PROFITABILITY

  • EPS (TTM)-1.32
  • P/E (TTM)-1.67
  • Fwd P/E (NTM)-1.53
  • EBITDA (TTM)-75.425M
  • ROE (TTM)-29.40%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On PMV Pharmaceuticals Inc

 

Profile

MORE
PMV Pharmaceuticals, Inc. is a precision oncology company, which is engaged in discovery and development of small molecule, tumor-agnostic therapies targeting p53. p53 is a tumor suppressor protein known as the guardian of the genome, and normal, or wild type, p53 has the ability to eliminate cancer cells. It is leveraging its precision oncology platform to develop a pipeline of orally available, potent and highly selective small molecule product candidates that target p53...
Richard Heyman Ph.D.
Independent Chairman of the Board
David Mack Ph.D.
President, Chief Executive Officer, Co-Founder, Director
Michael Carulli
Chief Financial Officer, Principal Accounting Officer
Address
One Research Way
Princeton, NJ
08540
United States

Top Peers

SYMBOLLASTCHG%CHG
ALLK
Allakos Inc
1.43-0.01-0.69%
LPTX
Leap Therapeutics Inc
2.57-0.06-2.28%
GNLX
Genelux Corp
4.30+0.65+17.81%
OTLK
Outlook Therapeutics Inc
7.95+0.17+2.19%
SGMT
Sagimet Biosciences Inc
4.74+0.12+2.60%